Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03732157
Other study ID # K180301J
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date November 2018
Est. completion date July 2019

Study information

Verified date September 2018
Source Assistance Publique - Hôpitaux de Paris
Contact Pierre CATTAN, Pr
Phone 0142499381
Email pierre.cattan@aphp.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The development of outpatient surgery has become a national priority, with the objective of an ambulatory surgery rate of around 50% in 2016, whereas this rate reached only 37.7% in 2010.

In the context of the management of primary hyperparathyroidism, there are two possible approaches. The first, which is commonly performed on an outpatient basis, consists in approaching only the pathological gland, if it was first identified by scintigraphy and ultrasound (which is the case in one patient in two), without exploring the others parathyroid glands.

The reference technique consists in exploring the 4 parathyroid sites by transverse cervicotomy. Although more invasive, it minimizes the risk of failure due to the lack of knowledge of multi-glandular forms of the disease (15 to 20%), whose preoperative diagnosis is difficult. This reference technique is poorly performed on an outpatient basis while it lends itself to this type of management because of the superficial character of the operative site, a short operating time, moderate postoperative pain, rapid return oral nutrition and exceptional and early serious complications (delay <24 h for cervical hematoma, <24 h for hypocalcemia and immediate diagnosis of recurrent palsy).

In this study, the investigators hypothesize that parathyroidectomy with 4-gland parathyroid exploration is feasible by ensuring patient safety. The investigators also believe that outpatient management will not lead to any difference after 3-month surgery, but will reduce hospitalization costs while increasing patient satisfaction with conventional care. To do so, the investigators carried out an observational cohort study of patients with an indication of parathyroidectomy wo will undergo outpatient management or conventional management (stay overnight in hospital) to inform all of these data.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 140
Est. completion date July 2019
Est. primary completion date July 2019
Accepts healthy volunteers No
Gender All
Age group 19 Years to 100 Years
Eligibility Inclusion Criteria:

- Patients > 18 years old

- Diagnosis of primary hyperparathyroidism (inappropriate parathyroid hormone secretion compared with calcemia)

- Surgical indication of parathyroidectomy with possible management outpatient or conventional hospitalization (choice of mode of care by the surgeon, after consultation with the patient)

Exclusion Criteria:

- Non-eligibility for outpatient surgery for general medical reasons (ASA score), determined during the consultation of preoperative anesthesia

- Preoperative hypercalcemia> 3 mmol / L (due to the high risk of postoperative hypocalcemia)

- History of cervicotomy for thyroidectomy or failure of parathyroid surgery

- Treatment of primary hyperparathyroidism with elective surgical approach

- Person under guardianship and curatorship

Study Design


Intervention

Procedure:
outpatient management of parathyroidectomy
The patient is discharged from hospital the same day of the parathyroidectomy intervention instead of conventional management (stay overnight in hospital)
conventional management of parathyroidectomy
The patient stays overnight in hospital after intervention

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion of conversion or readmission to conventional hospitalization The primary endpoint will be assessed for patients receiving outpatient management. Proportion of patients who could not discharged from hospital the same day of surgery as originally scheduled or being readmitted to conventional hospitalization within 8 days post operatively. within 8 days postoperatively
Secondary Postoperative pain evaluated using visual analogue scale (VAS) Pain will be evaluated using visual analogue scale (VAS) . VAS score ranges from 0 to 10. A high VAS score represents a high level of pain while a low VAS score represents a low level of pain. at day 0 post operatively
Secondary Postoperative pain evaluated using visual analogue scale (VAS) Pain will be evaluated using visual analogue scale (VAS) . VAS score ranges from 0 to 10. A high VAS score represents a high level of pain while a low VAS score represents a low level of pain. at day 1 post operatively
Secondary Postoperative pain evaluated using visual analogue scale (VAS) Pain will be evaluated using visual analogue scale (VAS) . VAS score ranges from 0 to 10. A high VAS score represents a high level of pain while a low VAS score represents a low level of pain. at day 8 post operatively
Secondary Proportion of patients with breathing difficulty. Dyspnea will be evaluated using the New York Heart Association (NYHA) Functional Classification. The stage of dyspnea is classified in four categories based on how much patients are limited during physical activity. Breathing difficulty will be defined by a stage of 3 on the NYHA scale. at day 1 post operatively
Secondary Proportion of patients with breathing difficulty. Dyspnea will be evaluated using the New York Heart Association (NYHA) Functional Classification. The stage of dyspnea is classified in four categories based on how much patients are limited during physical activity. Breathing difficulty will be defined by a stage of 3 on the NYHA scale. at day 8 post operatively
Secondary Proportion of patients with compressive cervical hematoma clinical evaluation based on the occurrence of a cervical collection that can obstruct the upper aero-digestive tract (NYHA scale dyspnea) at day 0 post operatively
Secondary Proportion of patients with compressive cervical hematoma clinical evaluation based on the occurrence of a cervical collection that can obstruct the upper aero-digestive tract (NYHA scale dyspnea) at day 1 post operatively
Secondary Proportion of patients with compressive cervical hematoma clinical evaluation based on the occurrence of a cervical collection that can obstruct the upper aero-digestive tract (NYHA scale dyspnea) at day 8 post operatively
Secondary Proportion of patients with hypocalcemia Hypocalcemia will be defined as calcemia lower than 2 mmol/L or 80 mg/L at day 1 post operatively
Secondary Proportion of patients with hypocalcemia Hypocalcemia will be defined as calcemia lower than 2 mmol/L or 80 mg/L at 3 months post operatively
Secondary Proportion of patients with recurrent nerve paralysis Clinical evaluation based on the occurrence of voice modification with swallowing disorder at day 0 post operatively
Secondary Proportion of patients with recurrent nerve paralysis Clinical evaluation based on the occurrence of voice modification with swallowing disorder at day 1 post operatively
Secondary Proportion of patients with recurrent nerve paralysis Clinical evaluation based on the occurrence of voice modification with swallowing disorder at day 8 post operatively
Secondary Patients' satisfaction regarding his/her care evaluated using visual analogue scale (VAS) Patients' satisfaction evaluated using visual analogue scale (VAS). VAS score ranges from 0 to 10. A high VAS score represents a high level of satisfaction while a low VAS score represents a low level of satisfaction. at day 0 post operatively
Secondary Patients' satisfaction regarding his/her care evaluated using visual analogue scale (VAS) Patients' satisfaction evaluated using visual analogue scale (VAS). VAS score ranges from 0 to 10. A high VAS score represents a high level of satisfaction while a low VAS score represents a low level of satisfaction. at day 1 post operatively
Secondary Patients' satisfaction regarding his/her care evaluated using visual analogue scale (VAS) Patients' satisfaction evaluated using visual analogue scale (VAS). VAS score ranges from 0 to 10. A high VAS score represents a high level of satisfaction while a low VAS score represents a low level of satisfaction. at 3 months post operatively
Secondary Total cost of mode of care Total cost of hospital surgery stay and hospital readmission at 3 months at 3 months post operatively
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03931109 - Circulating miRNA in Primary Hyperparathyroidism
Completed NCT04305561 - Preoperative Localization Strategies in Primary Hyperparathyroidism N/A
Recruiting NCT03052075 - Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism
Completed NCT03774771 - Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism Phase 2
Recruiting NCT02854345 - Preliminary Study Concerning the Validity of Parathyroid Exploration on a CZT Camera N/A
Completed NCT01222026 - Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate Phase 4
Recruiting NCT00973336 - Primary Hyperparathyroidism: Does a Systematic Treatment Improve the Calcium and Bone Metabolism After Surgery? Phase 2
Completed NCT01530919 - Minimally Invasive Radioguided Parathyroidectomy N/A
Recruiting NCT03605472 - Comparison of Cervical Ultrasound and Echoscintigraphy for Preoperative Localization Diagnosis in Primary Hyperparathyroidism N/A
Completed NCT01306656 - Vitamin D Repletion in Primary Hyperparathyroidism Phase 4
Terminated NCT00961701 - Lipids Profile in Primary Hyperparathyroidism N/A
Completed NCT00432939 - Primary Hyperparathyroidism: Non-classical Manifestations N/A
Completed NCT00522028 - Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Trial N/A
Completed NCT03713671 - Gait and Balance Parameters Before and After Parathyroidectomy in Patients With Primary Hyperparathyroidism N/A
Recruiting NCT04969926 - Natural History Study of Parathyroid Disorders
Recruiting NCT03039439 - Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
Completed NCT01996072 - EC17 for Intraoperative Imaging for Parathyroidectomy Phase 1
Completed NCT01460030 - An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism Phase 3
Enrolling by invitation NCT04085419 - Osteoporosis in Primary Hyperparathyroidism Phase 4
Recruiting NCT03935984 - Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity Phase 4